Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
5.46
-0.08 (-1.44%)
At close: Apr 28, 2026, 4:00 PM EDT
5.63
+0.17 (3.11%)
After-hours: Apr 28, 2026, 7:56 PM EDT
Verastem Market Cap
Verastem has a market cap or net worth of $479.62 million as of April 28, 2026. Its market cap has increased by 106.11% in one year.
Market Cap
479.62M
Enterprise Value
361.80M
1-Year Change
106.11%
Ranking
Category
Stock Price
$5.46
Market Cap Chart
Since January 27, 2012, Verastem's market cap has increased from $213.30M to $479.62M, an increase of 124.86%. That is a compound annual growth rate of 5.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 486.60M | -5.61% |
| Dec 31, 2025 | 515.50M | 124.03% |
| Dec 31, 2024 | 230.10M | 11.86% |
| Dec 29, 2023 | 205.70M | 143.14% |
| Dec 30, 2022 | 84.60M | -77.35% |
| Dec 31, 2021 | 373.50M | 3.29% |
| Dec 31, 2020 | 361.60M | 263.05% |
| Dec 31, 2019 | 99.60M | -59.81% |
| Dec 31, 2018 | 247.80M | 99.36% |
| Dec 29, 2017 | 124.30M | 200.24% |
| Dec 30, 2016 | 41.40M | -39.74% |
| Dec 31, 2015 | 68.70M | -70.98% |
| Dec 31, 2014 | 236.70M | -19.05% |
| Dec 31, 2013 | 292.40M | 56.53% |
| Dec 31, 2012 | 186.80M | -12.42% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AgomAb Therapeutics NV | 538.54M |
| Tectonic Therapeutic | 535.88M |
| enGene Therapeutics | 535.25M |
| Lyell Immunopharma | 522.79M |
| Eikon Therapeutics | 522.71M |
| Immix Biopharma | 522.17M |
| Fulcrum Therapeutics | 522.15M |
| Zura Bio | 510.46M |